These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12924645)

  • 21. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.
    Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
    J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraobserver and Interobserver Agreement in the Evaluation of Tumor Vascularization With Computed Tomography Perfusion in Cirrhotic Patients With Hepatocellular Carcinoma.
    Ippolito D; Casiraghi AS; Talei Franzesi C; Bonaffini PA; Fior D; Sironi S
    J Comput Assist Tomogr; 2016; 40(1):152-9. PubMed ID: 26484957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
    Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
    Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings.
    Honda H; Tajima T; Kajiyama K; Kuroiwa T; Yoshimitsu K; Irie H; Aibe H; Shimada M; Masuda K
    AJR Am J Roentgenol; 1999 Nov; 173(5):1213-7. PubMed ID: 10541091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
    Kaufmann S; Horger T; Oelker A; Kloth C; Nikolaou K; Schulze M; Horger M
    Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
    Chung GE; Lee JH; Yoon JH; Myung SJ; Lee K; Jang JJ; Lee JM; Kim SH; Suh KS; Kim YJ; Lee HS
    Abdom Imaging; 2012 Jun; 37(3):439-46. PubMed ID: 21584634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens.
    Takayasu K; Muramatsu Y; Mizuguchi Y; Moriyama N; Ojima H
    Intervirology; 2004; 47(3-5):199-208. PubMed ID: 15383730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective study.
    Boozari B; Soudah B; Rifai K; Schneidewind S; Vogel A; Hecker H; Hahn A; Schlue J; Dietrich CF; Bahr MJ; Kubicka S; Manns MP; Gebel M
    Dig Liver Dis; 2011 Jun; 43(6):484-90. PubMed ID: 21377941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
    Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
    Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to hepatitis C virus and nonalcoholic steatohepatitis.
    Takahashi H; Suzuki M; Ikeda H; Kobayashi M; Sase S; Yotsuyanagi H; Maeyama S; Iino S; Itoh F
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S7-S13. PubMed ID: 18986379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between blood flow velocity of feeding arteries and microvessel density of hepatocellular carcinoma].
    Dong L; Zhang CS; Guan YF; Zhang Y; Zhao XF
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):538-40. PubMed ID: 16438851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-enhanced ultrasound of hepatocellular carcinoma: Correlation of washout time and angiogenesis.
    Xia Y; Jiang YX; Dai Q; Xiao Y; Lv K; Wang L
    Clin Hemorheol Microcirc; 2011; 48(4):265-73. PubMed ID: 22012832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
    Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma: correlation of CT, angiographic, and histopathologic findings.
    Honda H; Ochiai K; Adachi E; Yasumori K; Hayashi T; Kawashima A; Fukuya T; Gibo M; Matsumata T; Tsuneyoshi M
    Radiology; 1993 Dec; 189(3):857-62. PubMed ID: 8234716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
    Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
    Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiphase hepatic scans with multirow-detector helical CT in detection of hypervascular hepatocellular carcinoma.
    Zhao H; Yao JL; Han MJ; Zhou KR; Yan FH
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):204-8. PubMed ID: 15138110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
    Bernstine H; Braun M; Yefremov N; Lamash Y; Carmi R; Stern D; Steinmetz A; Sosna J; Groshar D
    Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT.
    Zheng XH; Guan YS; Zhou XP; Huang J; Sun L; Li X; Liu Y
    World J Gastroenterol; 2005 Jan; 11(2):200-3. PubMed ID: 15633215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma in the caudate lobe of the liver: angiographic analysis of tumor-feeding arteries according to subsegmental location.
    Yoon CJ; Chung JW; Cho BH; Jae HJ; Kang SG; Kim HC; Choi YH; Jeon UB; Park JH
    J Vasc Interv Radiol; 2008 Nov; 19(11):1543-50; quiz 1550. PubMed ID: 18755606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.